Weiner Lab Investigates the Microbiome in Multiple Sclerosis (IMAGE)
Caption
Intestinal microbiome composition from healthy controls (HC), untreated MS patients (MS-U), and MS patients on disease modifying therapy (MS-Tr) measured on two different high-throughput DNA sequencing platforms, Roche 454 and Illumina MiSeq.
Credit
Howard Weiner, Brigham and Women's Hospital
Usage Restrictions
Reporters may freely use this image in their coverage of this paper with credit toHoward Weiner, Brigham and Women's Hospital
License
Licensed content